For families in remote villages across northeastern India, seeing a doctor often means long journeys over difficult terrain, lost daily wages, and sometimes, lifesaving treatment that comes too late.
Viatris Inc. and Kindeva Drug Delivery L.P. today announced the launch of Breyna™ Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort® with an Abbreviated New Drug Application approved by the U.S. Food and Drug Administration (FDA).
Competition from generic and biosimilar medicines is a fundamental component of health systems’ ability to expand and sustain patient access to medicines. Generic medicines generally represent between 60-80% of all medicine sales by volume in key markets globally,
The Mental Health Action Plan signals the IOC’s intent to integrate expert-led support for athletes’ well-being across multiple IOC programmes, working on complementary topics such as gender equality and safeguarding, with the support of Olympic Solidarity.
Illumina and Pillar Biosciences Inc., the pioneers of Decision Medicine™, announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products.
Comprehensive genomic profiling (CGP) assesses hundreds of tumor genes to find actionable mutations and is becoming the standard of care for many cancers. However, oncologists often opt for single-gene tests (SGT) before pursuing CGP.
Nothing about Budi Hermawan’s experience with tuberculosis (TB) has been easy. In 2003, he had a cough. He didn’t think much of it, but as his symptoms worsened, he visited a doctor near his home in Bogor, Indonesia.
Dental schools in two states are reaching underserved populations with dental care they otherwise might not get as a result of grants from Marathon Petroleum Corporation.
Everyone’s financial journey is different. We make intentional efforts to meet the individual needs of clients and communities through a diverse range...
Highlighting the top news, commentary, and research for the week coming from SHQ. The highlights newsletter also spotlights one profiled organization...
